We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-5.35%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$14.3B
AUM Growth
-$168M
Cap. Flow
+$80.2M
Cap. Flow %
0.56%
Top 10 Hldgs %
50.75%
Holding
806
New
78
Increased
577
Reduced
108
Closed
39

Sector Composition

Rank Sector Weight
1 Energy 59.62%
2 Financials 3.1%
3 Materials 2.91%
4 Healthcare 2.65%
5 Industrials 2.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBR icon
151
Vanguard Small-Cap Value ETF
VBR
$37.1B
$3.92M 0.03%
31,925
-105,702
-77% -$12.9M
BLUE
152
DELISTED
bluebird bio
BLUE
$3.88M 0.03%
2,853
+140
+5% +$169K
LKFT
153
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$3.51M 0.02%
45,868
+6,200
+16% +$521K
AAPL icon
154
Apple
AAPL
$4.89T
$3.46M 0.02%
96,060
+30,336
+46% +$1.12M
OGE icon
155
OGE Energy
OGE
$10.3B
$3.44M 0.02%
99,012
+910
+0.9% +$31.8K
CODI icon
156
Compass Diversified
CODI
$755M
$3.37M 0.02%
+192,983
New +$3.21M
NG icon
157
NovaGold Resources
NG
$2.6B
$3.34M 0.02%
732,631
-215,427
-23% -$927K
OPK icon
158
Opko Health
OPK
$921M
$3.32M 0.02%
504,924
+491,593
+3,688% +$3.45M
GFI icon
159
Gold Fields
GFI
$29.2B
$3.12M 0.02%
895,791
-557,773
-38% -$2.02M
MINT icon
160
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
$3.1M 0.02%
30,432
+760
+3% +$77.2K
ACAD icon
161
Acadia Pharmaceuticals
ACAD
$4.25B
$3.07M 0.02%
110,163
+5,968
+6% +$178K
SPG icon
162
Simon Property Group
SPG
$74.5B
$2.89M 0.02%
17,890
+2,500
+16% +$407K
PTLA
163
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.89M 0.02%
51,468
+2,823
+6% +$113K
AROC icon
164
Archrock
AROC
$6.33B
$2.85M 0.02%
249,837
+21,019
+9% +$241K
EQIX icon
165
Equinix
EQIX
$107B
$2.84M 0.02%
6,625
+20
+0.3% +$8.48K
SUPN icon
166
Supernus Pharmaceuticals
SUPN
$2.68B
$2.78M 0.02%
64,533
+3,950
+7% +$141K
NKTR icon
167
Nektar Therapeutics
NKTR
$2.39B
$2.74M 0.02%
+9,336
New +$2.7M
ICPT
168
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.73M 0.02%
22,573
+1,231
+6% +$143K
SAGE
169
DELISTED
Sage Therapeutics
SAGE
$2.69M 0.02%
33,709
+1,734
+5% +$125K
PSA icon
170
Public Storage
PSA
$60.2B
$2.64M 0.02%
12,666
-30
-0.2% -$6.45K
PLD icon
171
Prologis
PLD
$138B
$2.63M 0.02%
44,942
-150
-0.3% -$8.35K
ENDP
172
DELISTED
Endo International plc
ENDP
$2.56M 0.02%
229,138
+24,983
+12% +$293K
RARE icon
173
Ultragenyx Pharmaceutical
RARE
$2.65B
$2.37M 0.02%
38,165
+2,267
+6% +$137K
WELL icon
174
Welltower
WELL
$178B
$2.3M 0.02%
30,770
-170
-0.5% -$12.4K
LGND icon
175
Ligand Pharmaceuticals
LGND
$6.02B
$2.29M 0.02%
30,269
+1,510
+5% +$106K

Similar funds

ALPS Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, ALPS Advisors held 806 positions worth $14.3B, down 1.2% from $14.5B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

ALPS Advisors's Q2 2017 filing shows 78 new, 577 increased, 108 reduced and 39 closed positions. Its largest new stake was Brookfield: 2,292,089 shares worth $32.1M. The largest sale was Energy Transfer Partners L.p., an estimated $1.04B.

By sector, the portfolio is most concentrated in Energy at 60% of assets, down from 66% a quarter earlier, followed by Financials and Materials.

  • ALPS Advisors's largest Q2 2017 buy was Brookfield: 2,292,089 shares worth $32.1M.
  • ALPS Advisors added most to Energy Transfer Partners, L.P. in Q2 2017, an estimated $659M increase.
  • ALPS Advisors's biggest Q2 2017 reduction was Enterprise Products Partners, cutting an estimated $54.8M.
  • ALPS Advisors fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $1.04B.
  • ALPS Advisors's ten largest holdings make up 51% of its $14.3B portfolio in Q2 2017.
  • ALPS Advisors opened 78 new positions and closed 39 in Q2 2017.
  • ALPS Advisors's portfolio value fell 1.2% quarter-over-quarter to $14.3B.

Based on ALPS Advisors's 13F filing for Q2 2017, filed 3 Aug 2017.